NEUSoft™ UR842A NEUSoft™ UR852A NEUSoft™ UR862A NEUSoft™ UR873A Hardness 42 52 62 73 Specific Gravity 0.96 0.98 1.01 1.04 Compression Set 17 16 16 23 Tensile Strength @ 50% (psi) 130 185 265 455 Tensile Strength @ 100% (psi) 185 257 364 594 Tensile Strength @ 200% (psi) 305 392 532 830 Tensile Strength @ Break 990 1367 1849 2509 Elongation 501 575 626 542 Tear Resistance 120 164 234 319 Melt Index 190C/8.7kg 2 4 9 13 SELECTION GUIDE NEUSoft™ Thermoplastic Polyurethanes With continued advancement in healthcare technology, the importance of quick prototyping and material sampling has never been greater. For time-sensitive development projects, our NEUSoft Express offerings come in 14 standard colors, in neat or 20% barium sulfate-filled formulations, with a planned 14-day lead time to assist in accelerating your R&D process.

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: • The time required to consummate the acquisition of the Dyneema business, the satisfaction or waiver of conditions in the purchase agreement, the ability to obtain required regulatory or other third-party approvals and consents and otherwise consummate the proposed acquisition of the Dyneema business; • Our ability to achieve the strategic and other objectives relating to the proposed acquisition of the Dyneema business and possible sale of the Distribution business; • Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; • The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; • The current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows, including without any limitation, any supply chain and logistics issues; • Changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; • Fluctuations in raw material prices, quality and supply, and in energy prices and supply; • Production outages or material costs associated with scheduled or unscheduled maintenance programs; • Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; • Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; • Information systems failures and cyberattacks; • Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; and • Other factors described in our Annual Report on Form 10-K for the year ended 31 de diciembre de 2021 under Item 1A, “Risk Factors.” F I R S T Q U A R T E R 2 0 2 2 R E S U L T S $123 $136 2021 2022 $0.89 $0.99 2021 2022 Q1 2022 PERFORMANCE ( T O TA L C O M PA N Y ) 4 $1,162 $1,294 2021 2022 + 11% (+ 14% excluding FX) Adjusted EPS + 11% (+ 15% excluding FX) + 11% (+ 16% excluding FX) (in millions) (in millions) Sales Adjusted Operating Income Q1 2022 SEGMENT PERFORMANCE 5 CAI $609 $650 Sales ($ in millions) SEM Distribution $89 $95 Operating Income + 7% (+ 10% excluding FX) $363 $433 Sales $24 $24 Operating Income + 19% Flat (1) $217 $245 Sales $34 $40 Operating Income + 7% (+ 11% excluding FX) + 13% (+ 17% excluding FX) + 18% (+ 20% excluding FX) Q1 2021 $1,162 $123 Sustainable Solutions 19 8% 7 Healthcare 32 21% 6 Composites (excl. Purchase price multiple rapidly declining on strength of business and synergy capture (1) (1) (1) Financial information is pro forma to include a full year of Clariant Color acquisition ($ in millions) 11.9% 16.2% 2019PF 2021 EBITDA Margins (1) S P E C I A LT Y T R A N S F O R M AT I O N 7% 46% 66% 86% 100% 0% 20% 40% 60% 80% 100% 2005 2010 2015 2021 2022 PF % o f A dj us te d E B IT D A (1 ) JVs Distribution Performance Products & Solutions Specialty (1) Adjusted EBITDA is EBITDA excluding corporate costs and special items (2) Pro forma for the acquisition of Dyneema® and potential divestiture of Distribution (2) 29 12% 18% 16% 15% 15% 14% 14% 28% 28% 26% 25% 22% 21% 19% 16% 12% 9% 9% A vi en t T od ay A vi en t P F A V Y P P G K W R FU L R P M C E A LB FM C A S H E C L E M N H X L H U N S C L B N R U N V R Median: 21%Median: 15% 2 0 2 2 E B I T DA M A RG I N S V S .

S&P 500 All time high of $39.55 May 13th, 2014 PolyOne Corporation Page 12 2006 Q1 2014 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 13.8% 12 – 16% Global Specialty Engineered Materials 1.1% 11.6% 12 – 16% Designed Structures & Solutions -- 6.5% 8 – 10% Performance Products & Solutions 5.5% 7.7% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 64% 65 – 75% 3) ROIC* 5.0% 9.4% 15% 4) Adjusted EPS Growth N/A 42% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period PolyOne Corporation Page 13 Bridge to $2.50 Adjusted EPS by 2015 2015 EPS: $2.50 2013 EPS: $1.31 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental Share Buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid Single Digit Revenue CAGR PolyOne Corporation Page 14 Financial Highlights Bradley C. Richardson Executive Vice President, Chief Financial Officer PolyOne Corporation Page 15 Track Record of Accelerated Growth Total Revenue Adjusted EPS Adjusted EBITDA $2,061 $2,506 $2,709 $2,861 $3,771 2009 2010 2011 2012 2013 ($ in millions, except EPS ) $105 $179 $202 $255 $344 2009 2010 2011 2012 2013 $0.13 $0.68 $0.82 $1.00 $1.31 2009 2010 2011 2012 2013 PolyOne Corporation Page 16 $0.31 $0.44 $0.20 $0.30 $0.40 Q1 2013 Q1 2014 Adjusted EPS $42 $60 $20 $40 $60 Q1 2013 Q1 2014 Specialty Operating Income ($ millions) Q1 2014 Financial Highlights  Growth momentum accelerates driven by specialty platform  Specialty segments and Distribution achieve record results  All segments increase operating income compared to prior year  Revenue grew 25% versus Q1 2013 +43% +42% $57 $79 $30 $60 $90 Q1 2013 Q1 2014 Adjusted Operating Income ($ millions) +39% PolyOne Corporation Page 17 Commitment to Operational Excellence 81% 96% 2006 2013 16.2% 10.9% 2006 2013 On-Time Delivery Working Capital % of Sales 5.0% 31.0% 2006 2013 Percent of Associates Trained in LSS  Three consecutive years – CFO Magazine Best Working Capital Management Program in the chemical industry World’s Best Business Process Excellence Program in 2012*  95 certified Black Belts  211 certified Green Belts  422 Project Leaders World’s Best “Start-up Program” for Lean Six Sigma Deployment in 2009* *Both awards received from International Quality and Productivity Center PolyOne Corporation Page 18 Debt Maturities & Pension Funding – 3/31/14 Net Debt / EBITDA* = 1.9x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of 31 de marzo de 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% *TTM 12/31/2013 ** includes US-qualified pension plans only 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of 31 de marzo de 2014 PolyOne Corporation Page 19 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return $0.16 $0.20 $0.24 $0.32 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend  Expanding our sales, marketing, and technical capabilities  Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin  Synergy opportunities  Adjacent material solutions  Repurchased 1.4 million shares in Q1 2014  Repurchased 6.4 million shares since April 2013  13.6 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends  Investing in operational and LSS initiatives (including synergy capture)  Manufacturing alignment PolyOne Corporation Page 20 3.07 3.05 1.81 1.45 1.82 1.54 0.85 3.15 1.17 1.69 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 0.91 PolyOne Valuation Aspirations PEG Ratio Comparison Represents $38 of share price upside Avg = 1.96 PolyOne Corporation Page 21 Innovating for the Future Dr. Patterson President and Chief Executive Officer PolyOne Corporation Page 36 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 37 Innovation Drives Earnings Growth $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* *Percentage of Specialty Platform revenue from products introduced in last five years 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 43.0% 2006 2013 PolyOne Corporation Page 38 Formula for Success Innovation Market Beating Performance Excellence in Execution PolyOne Corporation Page 39 Track Record of Successful Integrations and Rapid Operating Income Growth $12 $44 2007 2013 $22 $30 2012 2013 $24 $49 2012 2013 GLS ColorMatrix Spartech OI in $ millions PolyOne Corporation Page 40 2015 and Beyond Innovation will drive the next stage in our remarkable transformation Deliver on 2015 goals Expand Specialty offerings and possibilities Identified as a truly global, specialty chemical company Market Potential Exceeds $40 Billion PolyOne Corporation Page 41 Driving Toward Premier Profitability EBIT Margins for top tier companies Victrex 42% Sigma Aldrich 18% FMC 25% IFF 18% Eastman 17% Hexcel 16% 16% Rockwood Holdings Celanese 14% 7% EBIT Margin – 2013 Albemarle 24% Ecolab 13% PolyOne Corporation Page 42 Bright Future & High Aspirations – The Next Seven Years • % OP Income from Specialty - 5% • Market Cap - $500 Million • Revenue - $2.6 Billion • Commodity Peers • Specialty ROS - 1.5% • % OP Income from Specialty - 62% • Market Cap - $3.5 Billion • Revenue - $3.7 Billion • Specialty ROS - 9.4% • % OP Income from Specialty - 80 to 90% • Market Cap - $12 to $18 Billion • Revenue - $8 to $10 Billion • Specialty Peers • Specialty ROS - ≥ 20% 2000 – 2006 2007 – 2013 2014 – 2020 PolyOne Corporation Page 43 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?

S&P 500 All time high of $39.55 May 13th, 2014 PolyOne Corporation Page 12 2006 Q1 2014 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 13.8% 12 – 16% Global Specialty Engineered Materials 1.1% 11.6% 12 – 16% Designed Structures & Solutions -- 6.5% 8 – 10% Performance Products & Solutions 5.5% 7.7% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 64% 65 – 75% 3) ROIC* 5.0% 9.4% 15% 4) Adjusted EPS Growth N/A 42% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period PolyOne Corporation Page 13 Bridge to $2.50 Adjusted EPS by 2015 2015 EPS: $2.50 2013 EPS: $1.31 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental Share Buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid Single Digit Revenue CAGR PolyOne Corporation Page 14 Financial Highlights Bradley C. Richardson Executive Vice President, Chief Financial Officer PolyOne Corporation Page 15 Track Record of Accelerated Growth Total Revenue Adjusted EPS Adjusted EBITDA $2,061 $2,506 $2,709 $2,861 $3,771 2009 2010 2011 2012 2013 ($ in millions, except EPS ) $105 $179 $202 $255 $344 2009 2010 2011 2012 2013 $0.13 $0.68 $0.82 $1.00 $1.31 2009 2010 2011 2012 2013 PolyOne Corporation Page 16 $0.31 $0.44 $0.20 $0.30 $0.40 Q1 2013 Q1 2014 Adjusted EPS $42 $60 $20 $40 $60 Q1 2013 Q1 2014 Specialty Operating Income ($ millions) Q1 2014 Financial Highlights  Growth momentum accelerates driven by specialty platform  Specialty segments and Distribution achieve record results  All segments increase operating income compared to prior year  Revenue grew 25% versus Q1 2013 +43% +42% $57 $79 $30 $60 $90 Q1 2013 Q1 2014 Adjusted Operating Income ($ millions) +39% PolyOne Corporation Page 17 Commitment to Operational Excellence 81% 96% 2006 2013 16.2% 10.9% 2006 2013 On-Time Delivery Working Capital % of Sales 5.0% 31.0% 2006 2013 Percent of Associates Trained in LSS  Three consecutive years – CFO Magazine Best Working Capital Management Program in the chemical industry World’s Best Business Process Excellence Program in 2012*  95 certified Black Belts  211 certified Green Belts  422 Project Leaders World’s Best “Start-up Program” for Lean Six Sigma Deployment in 2009* *Both awards received from International Quality and Productivity Center PolyOne Corporation Page 18 Debt Maturities & Pension Funding – 3/31/14 Net Debt / EBITDA* = 1.9x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of 31 de marzo de 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% *TTM 12/31/2013 ** includes US-qualified pension plans only 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of 31 de marzo de 2014 PolyOne Corporation Page 19 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return $0.16 $0.20 $0.24 $0.32 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend  Expanding our sales, marketing, and technical capabilities  Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin  Synergy opportunities  Adjacent material solutions  Repurchased 1.4 million shares in Q1 2014  Repurchased 6.4 million shares since April 2013  13.6 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends  Investing in operational and LSS initiatives (including synergy capture)  Manufacturing alignment PolyOne Corporation Page 20 3.07 3.05 1.81 1.45 1.82 1.54 0.85 3.15 1.17 1.69 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 0.91 PolyOne Valuation Aspirations PEG Ratio Comparison Represents $38 of share price upside Avg = 1.96 PolyOne Corporation Page 21 Innovating for the Future Dr. Patterson President and Chief Executive Officer PolyOne Corporation Page 36 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 37 Innovation Drives Earnings Growth $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* *Percentage of Specialty Platform revenue from products introduced in last five years 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 43.0% 2006 2013 PolyOne Corporation Page 38 Formula for Success Innovation Market Beating Performance Excellence in Execution PolyOne Corporation Page 39 Track Record of Successful Integrations and Rapid Operating Income Growth $12 $44 2007 2013 $22 $30 2012 2013 $24 $49 2012 2013 GLS ColorMatrix Spartech OI in $ millions PolyOne Corporation Page 40 2015 and Beyond Innovation will drive the next stage in our remarkable transformation Deliver on 2015 goals Expand Specialty offerings and possibilities Identified as a truly global, specialty chemical company Market Potential Exceeds $40 Billion PolyOne Corporation Page 41 Driving Toward Premier Profitability EBIT Margins for top tier companies Victrex 42% Sigma Aldrich 18% FMC 25% IFF 18% Eastman 17% Hexcel 16% 16% Rockwood Holdings Celanese 14% 7% EBIT Margin – 2013 Albemarle 24% Ecolab 13% PolyOne Corporation Page 42 Bright Future & High Aspirations – The Next Seven Years • % OP Income from Specialty - 5% • Market Cap - $500 Million • Revenue - $2.6 Billion • Commodity Peers • Specialty ROS - 1.5% • % OP Income from Specialty - 62% • Market Cap - $3.5 Billion • Revenue - $3.7 Billion • Specialty ROS - 9.4% • % OP Income from Specialty - 80 to 90% • Market Cap - $12 to $18 Billion • Revenue - $8 to $10 Billion • Specialty Peers • Specialty ROS - ≥ 20% 2000 – 2006 2007 – 2013 2014 – 2020 PolyOne Corporation Page 43 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?

% Pigment Specific Gravity Color Index Lightfastness WHITE 10PEP03 Titanium Dioxide, Rutile 60 2.06 PW-6 I/O YELLOW 12PEP01 Diarylide AAOT GS 20 1.24 PY-14 I 12PEP03 Diarylide HR RS 25 1.23 PY-83 I/O (Mass) 13PEP02 Isoindolinone RS 25 1.31 PY-110 I/O 13PEP03 Benzimidazolone GS 25 1.25 PY-151 I/O (Mass) 81PEP01 Iron Oxide 60 2.07 PY-42 I/O ORANGE 15PEP03 Benzimidazolone RS 25 1.27 PO-36 I/O RED 23PEP04 Quinacridone BS 25 1.24 PV-19 I/O 23PEP06 Specialty Naphthol BS 25 1.23 PR-170 I/O (Mass) C 25PEP01 Red 2B, Ca Salt BS 17 1.26 PR-48:2 I/O (Mass) 28PEP01 Red 2B, Ba Salt YS 25 1.32 PR48:1 I/O (Mass) 82PEP01 Iron Oxide, Light YS 27 1.5 PR-101 I/O 82PEP02 Iron Oxide, Light BS 60 2.2 PR-101 I/O 82PEP04 Iron Oxide, Light VYS 60 2.2 PR-101 I/O 82PEP05 Iron Oxide, Dark VBS 60 2.21 PR-101 I/O BLUE 40PEP01 Phthalocyanine GS 25 1.27 PB-15:3 I/O 40PEP05 Phthalocyanine RS 25 1.27 PB-15 I/O 42PEP02 Ultramarine 35 1.44 PB-29 I/O 49PEP01 Cobalt 31 1.54 PB-28 I/O GREEN 50PEP01 Phthalocyanine BS 16 1.28 PG-7 I/O 50PEP03 Phthalocyanine YS 16 1.28 PG-7 I/O 59PEP02 Chromium Oxide 70 2.6 PG-17 I/O VIOLET/MAGENTA 24PEP03 Quinacridone Violet 20 1.24 PV-19 I/O 24PEP04 Ultramarine Violet 50 1.69 PV-15 I/O 24PEP05 Quinacridone Magenta 20 1.24 PR-122 I/O 24PEP06 Benzimidazolone 20 1.23 PV-32 I/O 24PEP07 Carbazole Violet 13 1.22 PV-23 I/O BROWN/TAN 83PEP01 Iron Oxide, Light 34 1.6 PBr-6 I/O 83PEP02 Iron Oxide, Dark 29 1.51 PBr-6 I/O BLACK 90PEP01 Furnace - High Jet 24 1.3 PBk-7 I/O 90PEP04 Furnace - Medium 17 1.27 PBk-7 I/O 90PEP05 Iron Oxide 33 1.58 PBk-11 I/O POLYESTER URETHANE PASTE COLORANTS (PEP) Stan-Tone Code Pigment Type Approx. % Pigment Specific Gravity Color Index Lightfastness WHITE 10ET03 Titanium Dioxide, Rutile 56 1.74 PW-6 I/O YELLOW 12ET01 Diarylide AAOT GS 40 1.15 PY-14 I 12ET03 Diarylide HR RS 20 1.07 PY-83 I/O (Mass) 13ET02 Isoindolinone RS 20 1.11 PY-110 I/O 13ET03 Benzimidazolone GS 20 1.08 PY-151 I/O (Mass) 81ET01 Iron Oxide 60 1.84 PY-42 I/O ORANGE 15ET03 Benzimidazolone RS 25 1.11 PO-36 I/O RED 20ET01 Red Lake C YS 30 1.16 PR-53 I 22ET01 Lithol Rubine BS 30 1.17 PR-57:1 I 23ET04 Quinacridone BS 15 1.05 PV-19 I/O 23ET06 Specialty Naphthol BS 30 1.09 PR-170 I/O (Mass) C 25ET01 Red 2B, Ca Salt BS 29 1.15 PR-48:2 I/O (Mass) 28ET01 Red 2B, Ba Salt YS 30 1.18 PR-48:1 I/O (Mass) 82ET01 Iron Oxide, Light BS 60 1.94 PR-101 I/O 82ET02 Iron Oxide, Dark VBS 60 1.95 PR-101 I/O 82ET04 Iron Oxide, Light VYS 60 1.94 PR-101 I/O BLUE 40ET01 Phthalocyanine GS 25 1.11 PB-15:3 I/O 40ET05 Phthalocyanine RS 20 1.09 PB-15 I/O 42ET02 Ultramarine 55 1.46 PB-29 I/O 49ET01 Cobalt 65 2.02 PB-28 I/O GREEN 50ET01 Phthalocyanine BS 30 1.2 PG-7 I/O 50ET03 Phthalocyanine YS 25 1.16 PG-7 I/O 59ET01 Chromium Oxide 65 2.12 PG-17 I/O VIOLET/MAGENTA 24ET03 Quinacridone Violet 20 1.08 PV-19 I/O 24ET04 Ultramarine Violet 60 1.66 PV-15 I/O 24ET05 Quinacridone Magenta 20 1.08 PR-122 I/O 24ET06 Benzimidazolone 25 1.08 PV-32 I/O 24ET07 Carbazole Violet 13 1.05 PV-23 I/O BROWN/TAN 83ET01 Iron Oxide, Light 64 2.02 PBr-6 I/O 83ET02 Iron Oxide, Dark 60 1.9 PBr-6 I/O BLACK 90ET04 Furnace - Medium 22 1.12 PBk-7 I/O 90ET05 Iron Oxide 60 1.9 PBk-11 I/O POLYETHER URETHANE PASTE COLORANTS (ET) PEP/ET RS = Red Shade YS = Yellow Shade VYS = Very Yellow Shade BS = Blue Shade VBS = Very Blue Shade GS = Green Shade HR = Heat-Resistant LIGHTFASTNESS I = Indoor Only I/O = Indoor or Outdoor Mass = Outdoor Masstone Application Only C = Some Caution Advised www.avient.com Copyright © 2020, Avient Corporation.

S&P 500 PolyOne Corporation Page 14 Well Positioned for Accelerated Growth $40 billion of market potential • Megatrends favor our solutions $1.9 billion of opportunities in our specialty innovation pipeline • Increased $200m from a year ago 44% of Specialty products introduced in the last 5 years World class leadership team drives next phase of specialty transformation: From Gold to Platinum PolyOne Corporation Page 15 Global Color, Additives & Inks John V. Patterson President and Chief Executive Officer PolyOne Corporation Page 82 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 83 Confirmation of Our Strategy The World’s Premier Provider of Specialized Polymer Materials, Services and Solutions Specialization Globalization Operational Excellence Commercial Excellence PolyOne Corporation Page 84 ‘06-‘14 Adjusted EPS CAGR = 40% Strategy and Execution Drive Results $0.12 $0.27 $0.21 $0.13 $0.68 $0.82 $1.00 $1.31 $1.80 '06 '07 '08 '09 '10 '11 '12 '13 '14 Adjusted EPS Share Price vs. S&P 500 -100% 0% 100% 200% 300% 400% 500% 600% POL S&P 500 PolyOne Corporation Page 85 Formula for Success Innovation Market Beating Performance Excellence in Execution PolyOne Corporation Page 86 Track Record of Successful Acquisitions $12 $50 2007 2014 $22 $39 2012 2014 $24 $69 2012 2014 GLS ColorMatrix Spartech OI in $ millions PolyOne Corporation Page 87 Driving Toward Premier Profitability EBIT Margins for top tier companies Victrex 41% 18% Albemarle Eastman 17% Hexcel 17% FMC 16% Ecolab 14% 12% Specialty EBIT Margin – 2014 IFF 19% Celanese 13% PolyOne Corporation Page 88 2006 2014 2020 “Where we were” “Where we are” Platinum Vision Operating Income % Specialty: Global Color, Additives & Inks 1.7% 14.7% 20%+ Global Specialty Engineered Materials 1.1% 12.1% 20%+ Designed Structures & Solutions 1.4%(2012) 7.3% 12 – 14% Performance Products & Solutions 5.5% 7.7% 10 – 12% Distribution 2.6% 6.1% 6.5 – 7.5% Specialty Platform % of Operating Income 6.0% 65% 80%+ ROIC 5.0% 11.3% 15% Adjusted EPS Growth N/A 37% Double Digit Expansion 2020 Platinum Vision PolyOne Corporation Page 89 Platinum Vision: Pathway to Accelerated Growth Organic Sales Growth Margin Expansion Share Repurchases Acquisitions PolyOne Corporation Page 90 2006 2010 2014 2020 Driving Toward a Premium Specialty Multiple 6x 4x Commodity POL 8x Hybrid 10x 14x+ Mid-Tier Specialty Premium Specialty M ul tip le POL POL POL PolyOne Corporation Page 91 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?

For time-sensitive development projects, NEUSoft Express formulations offer 14 standard colors in the U.S. with a planned 14-day lead time. Colorable and offering a NEUSoft Express palette with a planned 14-day lead time 42

% Solids Color Index pH Typical Weight Lbs/Gal WHITE 10WDN03 Titanium Dioxide, Rutile 60 73 PW-6 9 16.7 YELLOW 12WDN01 Diarylide AAOT GS 35 43 PY-14 8.8 9.4 12WDN02 Diarylide HR RS 37 44 PY-83 8.8 9.6 12WDN03 Arylide GY RS 38 45 PY-74 8.8 9.2 81WDN01 Iron Oxide 55 63 PY-42 8.8 14.5 ORANGE 15WDN01 Pryazolone YS 40 45 PO-13 8.8 9.2 15WDN03 Dianisidine RS 35 37 PO-16 8.8 9.2 15WDN06 DNA Orange RS 31 43 PO-5 8.8 9.7 RED 22WDN01 Lithol Rubine BS 33 40 PR-57 8.8 9.8 21WDN01 Naphthol BS 35 43 N/A 8.8 9.5 25WDN01 Red 2B, Ca BS 34 41 PR-48:2 8.8 9.6 28WDN01 Red 2B, Ba YS 36 44 PR-48:1 8.8 9.5 82WDN02 Iron Oxide 57 66 PR-101 8.8 16 BLUE 40WDN01 Phthalocyanine RS 35 46 PB-15 8.8 9.7 40WDN03 Phthalocyanine GS 38 43 PB-15:3 8.8 9.8 GREEN WDN-27822 Phthalocyanine BS 42 53 PG-7 8.8 10.5 VIOLET/MAGENTA 24WDN02 Carbazole 35 48 PV-23 8.8 9.6 24WDN03 Quinacridone 31 39 PV-19 8.8 9.6 24WDN05 Quinacridone 30 41 PR-122 8.8 10 BLACK 90WDN01 Carbon Black 45 49 PB-7 8.8 9.3 WDN RS = Red Shade YS = Yellow Shade BS = Blue Shade GS = Green Shade HR = Heat-Resistant www.avient.com Copyright © 2020, Avient Corporation.

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: • Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; • The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; • The current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows including without any limitation, any supply chain and logistics issues • Our ability to achieve the strategic and other objectives relating to the acquisition of Clariant’s Masterbatch business, including any expected synergies; • Changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; • Fluctuations in raw material prices, quality and supply, and in energy prices and supply; • Production outages or material costs associated with scheduled or unscheduled maintenance programs; • Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; • An inability to achieve the anticipated financial benefit from initiatives related to acquisition and integration working capital reductions, cost reductions and employee productivity goals; • Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; • Information systems failures and cyberattacks; • Our ability to consummate and successfully integrate acquisitions; • Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; and • Other factors described in our Annual Report on Form 10-K for the year ended 31 de diciembre de 2020 under Item 1A, “Risk Factors.” Q 2 2 0 2 1 P E R F O R M A N C E U P D AT E $69 $122 2020PF 2021 $0.42 $0.87 2020PF 2021 Q2 2021 – ORGANIC PERFORMANCE ( T O TA L C O M PA N Y ) 4 Sales Adjusted Operating Income $870 $1,235 2020PF 2021 + 42% Adjusted EPS + 77% + 107% (in millions) (in millions) (1) (1) (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Q2 2021 SEGMENT PERFORMANCE 5 CAI $488 $624 Sales ($ in millions) SEM Distribution $54 $86 Operating Income +28% +59% $239 $404 Sales $15 $24 Operating Income +69% +60% (1) $159 $241 Sales $17 $37 Operating Income +52% +118% (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition SPECIALTY EBITDA MARGIN EXPANSION 6 CAI (1) 2018-2020 financial information is pro forma to include a full year of Clariant Masterbatch business acquisition 15.3% 15.2% 16.2% 18.5% 2018 2019 2020 YTD 2021 14.8% 15.2% 17.6% 19.1% 2018 2019 2020 YTD 2021 (1) SEM • Continued portfolio transformation to high-growth end markets and sustainable solutions • Clariant Masterbatch synergy realization • Investments in composites and outdoor high performance applications drive growth and mix improvements CAI EBITDA MARGIN EXPANSION 7 Legacy CAI 18.9% 18.9% 20.3% 2019 2020 YTD 2021 Legacy Clariant MB 11.9% 13.8% 16.8% 2019 2020 YTD 2021 • Synergy capture translating to the bottom line • Positive mix with growth in healthcare, consumer and packaging end-markets • World-class vitality index of 35% represents sales from products introduced in the last five years. ColorWorks innovation centers are specially designed to foster imagination and enable creative exploration of innovative solutions • Focus on customers’ sustainability initiatives through recyclability and post-consumer recycled materials for packaging applications • Supports 8-12% long-term revenue growth expectations across our sustainable solutions portfolio 8 2020 Pro forma $870 $69 Sustainable Solutions 66 37% 26 Healthcare 29 20% 7 Composites 12 36% 6 Growth in Asia / LATAM 47 39% 11 Other 190 48% 22 Sub-total $1,214 40% $141 COVID Response Applications (15) (8) FX Impact 36 4 Synergies 11 Incentives, Travel, Other Employee Costs (26) 2021 Actual $1,235 42% $122 Q2 2021 ORGANIC SALES AND OPERATING INCOME ( T O TA L C O M PA N Y ) 9 (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Sales Growth Rate Adjusted Operating Income$ millions (1) 10 Q2 2020PF Q2 2021 (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition (2) Financial information is presented on a constant currency basis (1,2) (44% of total revenue) (56% of total revenue) Q2 END MARKET SALES PERFORMANCE +26% +38% +46% +103% +51% +9% +7% +67% Energy Telecom Building & Construction Transportation Industrial Healthcare Packaging Consumer Q2 YEAR-OVER-YEAR EBITDA BRIDGE Q2 2020 Pro forma $ 106 Demand 69 11 Adjusted EBITDA$ millions • Demand impact driven by growth in sustainable solutions and consumer products • Price increases more than offset raw material and supply chain impacts (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition (1) CAI: Price / Mix 40 Inflation (32) SEM: Price / Mix 23 Inflation (18) Distribution: Price / Mix 81 Inflation (77) Net Price Benefit 17 Supply Chain Disruptions (14) COVID Response Applications (8) Synergies 11 Incentives, Travel, FX, Other (22) Q2 2021 Actual $ 159     Q1 2021 Actual $ 161 CAI: Price / Mix 32 Inflation (22) SEM: Price / Mix 15 Inflation (9) Distribution: Price / Mix 50 Inflation (48) Net Price Benefit 18 Supply Chain Disruptions (12) Demand / Seasonality (6) Other (2) Q2 2021 Actual $ 15912 Adjusted EBITDA$ millions • Price increases more than offset raw material and freight inflation impacts • Demand impact driven by Q2 seasonality for the business Q1 TO Q2 SEQUENTIAL EBITDA BRIDGE     Q 3 A N D F U L L Y E A R 2 0 2 1 O U T L O O K $74 $98 2020 2021E $0.46 $0.68 2020 2021E ORGANIC GROWTH PROJECTIONS – Q3 ( T O TA L C O M PA N Y ) 14 Sales Adjusted Operating Income $925 $1,150 2020 2021E + 24% Adjusted EPS + 32% + 48% (in millions) (in millions) FULL YEAR GUIDANCE INCREASED 15 Sales Adj.

% Pigment Specific Gravity Color Index Lightfastness WHITE 10EPX03 Titanium Dioxide, Rutile 57 1.95 PW-6 I/O YELLOW 12EPX01 Diarylide AAOT GS 25 1.22 PY-14 I 12EPX03 Diarylide HR RS 20 1.2 PY-83 I/O (Mass) 13EPX02 Isoindolinone RS 30 1.3 PY-110 I/O 13EPX03 Benzimidazolone GS 40 1.27 PY-151 I/O (Mass) 81EPX01 Iron Oxide 40 1.62 PY-42 I/O ORANGE 15EPX03 Benzimidazolone 30 1.26 PO-36 I/O RED 23EPX04 Quinacridone BS 25 1.21 PV-19 I/O 23EPX06 Specialty Naphthol BS 30 1.21 PR-170 I/O (Mass) C 25EPX01 Red 2B, Ca Salt Bs 24 1.27 PR-48:2 I/O (Mass) 28EPX01 Red 2B, Ba Salt YS 23 1.29 PR-48:1 I/O (Mass) 82EPX01 Iron Oxide, Light BS 40 1.67 PR-101 I/O 82EPX02 Iron Oxide, Dark BVS 40 1.68 PR-101 I/O 82EPX04 Iron Oxide, Light VYS 40 1.67 PR-101 I/O BLUE 40EXP03 Phthalocyanine GS 25 1.25 PB-15:3 I/O 40EXP05 Phthalocyanine RS 25 1.25 PB-15:3 I/O 42EXP02 Ultramarine 50 1.54 PB-29 I/O 49EXP01 Cobalt 50 1.83 PB-28 I/O GREEN 50EPX02 Phthalocyanine BS 18 1.34 PG-7 I/O 50EPX03 Phthalocyanine YS 25 1.42 PG-7 I/O 59EPX01 Chromium Oxide 40 1.64 PG-17 I/O VIOLET/MAGENTA 24EPX03 Quinacridone Violet 15 1.2 PV-19 I/O 24EPX04 Ultramarine Violet 50 1.66 PV-15 I/O 24EPX05 Quinacridone Magenta 20 1.21 PR-122 I/O 24EPX06 Benzimidazolone 20 1.2 PV-32 I/O 24EPX07 Carbazole Violet 15 1.2 PV-23 I/O BROWN/TAN 83EPX01 Iron Oxide, Light 39 1.64 PBr-6 I/O 83EPX02 Iron Oxide, Dark 40 1.66 PBr-6 I/O BLACK 90EPX01 Furnace - High Jet 14 1.23 PBk-7 I/O 90EPX04 Furnace - Medium 20 1.25 PBk-7 I/O 90EPX05 Iron Oxide 50 1.77 PBk-11 I/O EPX RS = Red Shade YS = Yellow Shade VYS = Very Yellow Shade BS = Blue Shade VBS = Very Blue Shade GS = Green Shade HR = Heat-Resistant LIGHTFASTNESS I = Indoor Only I/O = Indoor or Outdoor Mass = Outdoor Masstone Application Only C = Some Caution Advised www.avient.com Copyright © 2020, Avient Corporation.